Plexion
PLEXION Cream (sodium sulfacetamide 9.8%, sulfur 4.8%)
Approved
Approval ID
db71ee55-bbdd-0996-e053-2a95a90a5687
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Mar 30, 2022
Manufacturers
FDA
Eckson Labs LLC
DUNS: 078435242
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
SULFACETAMIDE SODIUM, SULFUR
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code44118-701
Product Classification
G
Generic Name
SULFACETAMIDE SODIUM, SULFUR
Product Specifications
Route of AdministrationTOPICAL
Effective DateMarch 30, 2022
FDA Product Classification
INGREDIENTS (2)
SULFURActive
Quantity: 48 mg in 1 g
Code: 70FD1KFU70
Classification: ACTIB
SULFACETAMIDE SODIUMActive
Quantity: 98 mg in 1 g
Code: 4NRT660KJQ
Classification: ACTIB